Bendheim Daniel M
Exec. VP, Corporate Strategy at PAHC
- Sold, on record
- $2.9M
- Dollars the filings state
- Form 4 sales
- 10
- Latest Jan 30, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- PAHCPHIBRO ANIMAL HEALTH CORPExec. VP, Corporate Strategy
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale PAHCUnusualMar 6, 2018 2018
Sold 3,960 shares at $40.06 ($159k)
Bendheim Daniel M, Exec. VP, Corporate Strategy
Sold 100% of holdings ($159k position)0 shares leftFiling
- 2 Form 4 sale PAHCUnusualMar 12, 2018 +6 days
Sold 23,163 shares at $40.01 ($927k)
Bendheim Daniel M, Exec. VP, Corporate Strategy
Sold 100% of holdings ($927k position)0 shares left4.7x usual sizeFiling
- 3 Form 4 sale PAHCUnusualSep 12, 2018 +184 days
Sold 2,500 shares at $44.30 ($111k)
Bendheim Daniel M, Exec. VP, Corporate Strategy
Sold 100% of holdings ($111k position)0 shares left0.4x usual sizeFiling
- 4 Form 4 sale PAHCUnusualJan 7, 2019 +117 days
Sold 7,500 shares at $31.74 ($238k)
Bendheim Daniel M, Exec. VP, Corporate Strategy
Sold 100% of holdings ($238k position)0 shares left1.5x usual sizeFiling
- 5 Form 4 sale PAHCUnusualJan 9, 2019 +2 days
Sold 5,000 shares at $32.43 ($162k)
Bendheim Daniel M, Exec. VP, Corporate Strategy
Sold 100% of holdings ($162k position)0 shares left0.8x usual sizeFiling
- 6 Form 4 sale PAHCUnusualJan 18, 2019 +9 days
Sold 7,500 shares at $32.23 ($242k)
Bendheim Daniel M, Exec. VP, Corporate Strategy
Sold 100% of holdings ($242k position)0 shares left1.5x usual sizeFiling
- 7 Form 4 sale PAHCUnusualJan 24, 2019 +6 days
Sold 7,500 shares at $31.63 ($237k)
Bendheim Daniel M, Exec. VP, Corporate Strategy
Sold 100% of holdings ($237k position)0 shares left1.2x usual sizeFiling
- 8 Form 4 sale PAHCUnusualJan 30, 2019 +6 days
Sold 9,780 shares at $31.34 ($306k)
Bendheim Daniel M, Exec. VP, Corporate Strategy
Sold 100% of holdings ($306k position)0 shares left1.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2019 | Jan 30, 2019 | PAHC | Exec. VP, Corporate Strategy | Form 4 sale | 9,780 | $306k | 100.0% | Unusual | SEC |
| Jan 24, 2019 | Jan 24, 2019 | PAHC | Exec. VP, Corporate Strategy | Form 4 sale | 7,500 | $237k | 100.0% | Unusual | SEC |
| Jan 18, 2019 | Jan 18, 2019 | PAHC | Exec. VP, Corporate Strategy | Form 4 sale | 7,500 | $242k | 100.0% | Unusual | SEC |
| Jan 9, 2019 | Jan 10, 2019 | PAHC | Exec. VP, Corporate Strategy | Form 4 sale | 5,000 | $162k | 100.0% | Unusual | SEC |
| Jan 7, 2019 | Jan 7, 2019 | PAHC | Exec. VP, Corporate Strategy | Form 4 sale | 7,500 | $238k | 100.0% | Unusual | SEC |
| Sep 12, 2018 | Sep 14, 2018 | PAHC | Exec. VP, Corporate Strategy | Form 4 sale | 2,500 | $111k | 100.0% | Unusual | SEC |
| Mar 12, 2018 | Mar 12, 2018 | PAHC | Exec. VP, Corporate Strategy | Form 4 sale | 23,163 | $927k | 100.0% | Unusual | SEC |
| Mar 6, 2018 | Mar 7, 2018 | PAHC | Exec. VP, Corporate Strategy | Form 4 sale | 3,960 | $159k | 100.0% | Unusual | SEC |
| Aug 21, 2017 | Aug 21, 2017 | PAHC | Exec. VP, Corporate Strategy | Form 4 sale | 4,976 | $199k | 100.0% | Unusual | SEC |
| Aug 16, 2017 | Aug 16, 2017 | PAHC | Exec. VP, Corporate Strategy | Form 4 sale | 7,681 | $308k | 100.0% | Unusual | SEC |